AnjleeMahajanMD

Hematologic Oncology

Assistant Professor, UC Davis Comprehensive Center

Dr. Mahajan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2013 - 2016
University of California Davis HealthResidency, Internal Medicine, 2009 - 2012
Albert Einstein College of MedicineClass of 2009

PubMed

Sickle cell trait does not cause "sickle cell crisis" leading to exertion-related death: a systematic review.
Lachelle D Weeks, Allecia M Wilson, Rakhi P Naik, Yvonne Efebera, M Hassan Murad
Blood. 2025-03-27
Evaluation of direct oral anticoagulants versus low molecular weight heparins for venous thromboembolism treatment in patients with gastrointestinal malignancies.
Tiffany Guan, Arianna Laguna, Alisha Soares, Carlo S Legasto, Shanna Block
Journal of Thrombosis and Thrombolysis. 2023-10-01
18 citations
Pregnancy outcomes in women with sickle cell disease in California.
Oyebimpe O Adesina, Ann Brunson, Samantha C Fisch, Bo Yu, Anjlee Mahajan
American Journal of Hematology. 2023-03-01

Abstracts/Posters

Fragmentation of Care for Young Adults with Sickle Cell Disease in California
Anjlee Mahajan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Cancer Specific Survival in Patients with Sickle Cell Disease
Anjlee Mahajan, MD, British Journal of Haematology, Orlando, FL, 12/9/2019

Young Sickle Cell Adult Patients Experience Increased Fragmented CareDecember 10th, 2019